HealthEquity, Inc. (NASDAQ: $HQY) reported its financial results for the third quarter ended October 31, 2024. The company achieved revenue of $300.4 million, representing a 21% increase from $249.2 million in the same quarter of the previous fiscal year. However, this figure fell short of analysts' expectations, which had estimated revenue of $305.3 million. HealthEquity's net income for the quarter was $5.7 million, a decline from $14.7 million in the prior year, while its non-GAAP net income rose to $69.4 million, up 33% from $52.2 million year-over-year. Adjusted earnings per share (EPS) were reported at $0.78, surpassing the estimate of $0.74. For the fiscal year 2025, HealthEquity projects an adjusted EPS between $3.08 and $3.16, compared to an estimate of $3.11, and expects revenue to be in the range of $1.185 billion to $1.195 billion, slightly above the estimated $1.184 billion.